Table 2.
Protein | p‐value | FDR adjusted p‐value | ∆ NPX | Fold change |
---|---|---|---|---|
(P)VRL versus other aetiologies | ||||
EZR | 2.1E‐12 | 3.5E‐10 | 3.2 | 1.9 |
ISOLD | 1.5E‐09 | 1.2E‐07 | n/a | n/a |
CCL8 | 1.7E‐05 | 9.5E‐04 | 2.5 | 1.5 |
IL‐10/IL‐6.ratio | 1.2E‐04 | 5.1E‐03 | n/a | n/a |
CCL2 | 2.6E‐04 | 7.6E‐03 | 1.3 | 1.1 |
Sarcoidosis versus TB‐associated | ||||
CCL17 | 9.9E‐06 | 1.7E‐03 | 3.9 | 4.2 |
CXCL13 | 1.6E‐04 | 1.3E‐02 | 3.2 | 1.7 |
Granulomatous (sarcoidosis and TB‐associated) versus other aetiologies | ||||
EZR | 1.5E‐04 | 2.4E‐02 | −1.8 | 0.6 |
CD8A | 4.5E‐04 | 2.4E‐02 | −1.7 | 0.4 |
GZMB | 5.4E‐04 | 2.4E‐02 | −2.1 | 0.4 |
GZMH | 6.8E‐04 | 2.4E‐02 | −2.1 | 0.5 |
CRTAM | 9.9E‐04 | 2.4E‐02 | −1.2 | 0.1 |
(P)VRL = primary vitreoretinal lymphoma, FDR = false discovery rate, NPX = normalized protein expression, PEA = proximity extension assay, TB = tuberculosis.